摘要:
Provided is a nucleic acid primer for LAMP amplification for use in the detection of human papilloma virus and identification of its genotype. The present invention also provides a method of detecting human papilloma virus and identifying its genotype, includes a step of amplifying the nucleic acid chains in a sample in LAMP reaction by using multiple primers including at least one primer selected from the nucleic acid primers according to the present invention and a step of detecting presence of amplified products after the amplification reaction and identifying their genotypes.
摘要:
The present invention provides a method of preparing a detection target structure useful for detecting a target nucleotide sequence. For example, provided is a method of preparing a detection target structure from a target nucleic acid (1). The target nucleic acid includes a target nucleotide sequence 2 in a part. According to the method of the present invention, a nucleic acid is elongated by using a primer so as to permit the target nucleic acid to have a double strand structure in the portion other than the target nucleotide sequence 2, thereby affording a detection target structure 4. The present invention also provides the detection target structure thus prepared a detection method of the target nucleotide sequence by using the detection target structure, a kit for preparing the detection target structure, and an assay kit for detecting the target nucleotide sequence.
摘要:
According to one aspect, a microarray for nucleic acid detection includes a substrate, a negative control probe group immobilized on a first region of the substrate and provided with a plurality of first probes having different sequences, and a second probe immobilized on a second region of the substrate and containing a sequence complementary to a target nucleic acid.
摘要:
Provided is a nucleic acid primer for LAMP amplification for use in the detection of human papilloma virus and identification of its genotype. The present invention also provides a method of detecting human papilloma virus and identifying its genotype, includes a step of amplifying the nucleic acid chains in a sample in LAMP reaction by using multiple primers including at least one primer selected from the nucleic acid primers according to the present invention and a step of detecting presence of amplified products after the amplification reaction and identifying their genotypes.
摘要:
Provided is an ORL-1 receptor agonist having improved bioavailability based on superior metabolic stability and strong and high selectivity, as compared to conventional compounds. A compound represented by the formula (I) wherein each symbol is as defined in the claims.
摘要:
The present invention aims to provide a stable form of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide, which is free of problems of water adsorption and the like, and shows superior water solubility.The present invention provides a crystal and a salt of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide in a crystal form.
摘要:
Provided is an ORL-1 receptor agonist having improved bioavailability based on superior metabolic stability and strong and high selectivity, as compared to conventional compounds. A compound represented by the formula (I) wherein each symbol is as defined in the claims.
摘要:
An agent composition for the therapy or prevention of the injury of an organ or a tissue containing a phenylthiazole derivative expressed by the following formula (1): ##STR1## (R.sub.1 is a C.sub.1 -C.sub.18 alkoxy group or a cyclic amino group; R.sub.2 is a cyano group or a nitro group; R.sub.3 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group), and/or its salt as an active ingredient.
摘要:
A calcium-magnesium carbonate composite consisting of particles of calcium carbonate and magnesium carbonate hydroxide and having excellent properties, for example, as a pigment for paper coating is proposed, which is a uniform blend of:(A) particles of calcium carbonate having a crystalline structure of aragonite with a columnar particle configuration having a length in the range from 0.5 to 3 .mu.m and a diameter in the range from 0.1 to 0.3 pm with an aspect ratio in the range from 5 to 15; and(B) particles of magnesium carbonate hydroxide having a plate-like particle configuration with a particle diameter in the range from 2 to 7 .mu.m and a thickness in the range from 0.05 to 0.5 .mu.m,the blend having an overall specific surface area in the range from 15 to 30 m.sup.2 /g and the weight proportion of the particles of calcium carbonate to the particles of magnesium carbonate hydroxide being in the range from 95:5 to 50:50 calculated as the respective hydroxides. The carbonate composite can be prepared by the step-wise carbonation reaction of a mixed aqueous slurry of calcium and magnesium hydroxides with carbon dioxide gas under very strictly controlled conditions.
摘要:
The present invention aims to provide a stable form of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide, which is free of problems of water adsorption and the like, and shows superior water solubility.The present invention provides a crystal and a salt of (R)-2-{3-[1-(acenaphthen-1-yl)piperidin-4-yl]-2,3-dihydro-2-oxo-benzimidazol-1-yl}-N-methylacetamide in a crystal form.